Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Open in API
Filings indexed 1,253 across all filing types
Latest filing 2016-08-03 Interim / Quarterly Rep…
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2016
2016-08-03 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 3, 2016, reporting the financial results for the quarter ended July 2, 2016. It specifically mentions that a press release announcing the financial results is attached as Exhibit 99.1. The text states this is a current report and includes a press release with second quarter financial results. The document length is 3382 characters, which is relatively short and primarily serves as an announcement of quarterly financial results rather than a full detailed report. According to the definitions, an initial announcement of quarterly financial results (key highlights only) corresponds to an Earnings Release (ER). The document is not a full interim report (IR) because it does not contain comprehensive financial statements or substantive financial data and analysis, but rather a press release announcing results. Therefore, the correct classification is Earnings Release (ER).
2016-08-03 English
FORM 4
Director's Dealing
2016-07-21 English
FORM 4
Director's Dealing
2016-07-21 English
8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated July 13, 2016. It reports the entry into a material definitive agreement (a new lease) and the creation of a direct financial obligation. The document is a regulatory filing that provides timely disclosure of significant corporate events but does not contain comprehensive financial statements or detailed financial analysis. It is not an annual or quarterly report, earnings release, or other detailed financial report. Therefore, it fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2016-07-18 English
Regulatory Filings 2016
Regulatory Filings
2016-07-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.